Pharmaceutical formulations and uses thereof
US12064516B2 · kind B2 · utility
1Cited by
81References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2021 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | Nov 13, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions and unit dosage forms comprising a quinoline compound, or a pharmaceutically acceptable salt thereof, which are useful for treatment of a disease, disorder, or condition such as inflammatory diseases, respiratory diseases, organ diseases, viral infections, and sequelae and associated conditions such as acute respiratory distress syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.